Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600871 · ClinicalTrials.gov registry record · Phase 4
Skin and Soft Tissue Infection (SSTI) Study
A Phase 4 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Phase 4
- Development phase
- 101
- Enrollment target
NCT02600871 is a Phase 4 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 101 participants.
The verdict
NCT02600871, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use Provodine as an antiseptic and hand wash once daily for at least 7 days will have better healing, better health outcomes, fewer treatment failures and fewer infections themselves and among their household contacts than those who do not use Provodine.
Interventions
- PROCEDURE Incision and Drainage
- DRUG Provodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-05-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02600871
The ClinicalTrials.gov registry entry for NCT02600871 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Incision and Drainage is the first listed.
NCT02600871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02600871 about?
NCT02600871 is a clinical study titled "Skin and Soft Tissue Infection (SSTI) Study". The purpose of this study is to determine if the use Provodine as an antiseptic and hand wash once daily for at least 7 days will have better healing, better health outcomes, fewer treatment failures and fewer infections themselves and among their household contacts than those who do not use Provodi...
What is the current status of trial NCT02600871?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 101 participants. The study started on 2015-12. Estimated completion is 2017-05-30.
What interventions are being tested in trial NCT02600871?
The interventions under investigation include: Incision and Drainage (PROCEDURE), Provodine (DRUG).
Who is sponsoring clinical trial NCT02600871?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.